Cargando…

Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems

BACKGROUND: Brain metastases (BM) are the most common form of intracranial cancer. The incidence of BM seems to have increased over the past decade. Recursive partitioning analysis (RPA) of data from three Radiation Therapy Oncology Group (RTOG) trials (1200 patients) has allowed three prognostic gr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viani, Gustavo A, Castilho, Marcus S, Salvajoli, João V, Pellizzon, Antonio Cassio A, Novaes, Paulo E, Guimarães, Flavio S, Conte, Maria A, Fogaroli, Ricardo C
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851018/ https://www.ncbi.nlm.nih.gov/pubmed/17386108 http://dx.doi.org/10.1186/1471-2407-7-53

Ejemplares similares

Whole brain radiation therapy in management of brain metastasis: results and prognostic factors
por: Saito, Elisa Y, et al.
Publicado: (2006)

Chemotherapy followed by low dose radiotherapy in childhood Hodgkin's disease: retrospective analysis of results and prognostic factors
por: Viani, Gustavo A, et al.
Publicado: (2006)

Preoperative external beam radiotherapy and reduced dose brachytherapy for carcinoma of the cervix: survival and pathological response
por: Jacinto, Alexandre A, et al.
Publicado: (2007)

Salvage radiotherapy for biochemical relapse after complete PSA response following radical prostatectomy: outcome and prognostic factors for patients who have never received hormonal therapy
por: Jacinto, Alexandre A, et al.
Publicado: (2007)

Intensity Modulated Radiotherapy (IMRT) in the postoperative treatment of an adenocarcinoma of the endometrium complicated by a pelvic kidney
por: Castilho, Marcus S, et al.
Publicado: (2006)

The relationship between the biochemical control outcomes and the quality of planning of high-dose rate brachytherapy as a boost to external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition
por: Pellizzon, Antonio Cassio Assis, et al.
Publicado: (2008)

High-risk surgical stage 1 endometrial cancer: analysis of treatment outcome
por: Viani, Gustavo A, et al.
Publicado: (2006)

Whole brain radiotherapy with radiosensitizer for brain metastases
por: Viani, Gustavo Arruda, et al.
Publicado: (2009)

High-dose-rate brachytherapy for soft tissue sarcoma in children: a single institution experience
por: Viani, Gustavo A, et al.
Publicado: (2008)

Local control after radiosurgery for brain metastases: predictive factors and implications for clinical decision
por: de Azevedo Santos, Tâmara Ribeiro, et al.
Publicado: (2015)

Salvage for cervical recurrences of head and neck cancer with dissection and interstitial high dose rate brachytherapy
por: Pellizzon, Antonio Cassio Assis, et al.
Publicado: (2006)

Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases
por: Xie, Xue-Yi, et al.
Publicado: (2022)

Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases
por: Jiang, Cecilia, et al.
Publicado: (2021)

Heterogeneity of HER2 Expression in Circulating Tumor Cells of Patients with Breast Cancer Brain Metastases and Impact on Brain Disease Control
por: de Castro, Douglas Guedes, et al.
Publicado: (2022)

Advances in radiotherapy for brain metastases
por: Gondi, Vinai, et al.
Publicado: (2021)

Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment
por: Tallet, Agnes V, et al.
Publicado: (2012)

Meta‐analysis of whole‐brain radiotherapy plus temozolomide compared with whole‐brain radiotherapy for the treatment of brain metastases from non‐small‐cell lung cancer
por: Xin, Yong, et al.
Publicado: (2018)

Randomized Trial of Erlotinib Plus Whole-Brain Radiotherapy for NSCLC Patients With Multiple Brain Metastases
por: Lee, Siow Ming, et al.
Publicado: (2014)

Upfront whole brain radiotherapy for multiple brain metastases in patients with EGFR-mutant lung adenocarcinoma
por: Li, Changhui, et al.
Publicado: (2019)

Re-Whole Brain Radiotherapy May Be One of the Treatment Choices for Symptomatic Brain Metastases Patients
por: Ono, Takashi, et al.
Publicado: (2022)

Does Time between Imaging Diagnosis and Initiation of Radiotherapy Impact Survival after Whole-Brain Radiotherapy for Brain Metastases?
por: Nieder, Carsten, et al.
Publicado: (2013)

Public health measures, radiotherapy, and the novel coronavirus outbreak
por: Pellizzon, Antonio Cassio Assis
Publicado: (2020)

Prospective Assessment of the Association Between Circulating Tumor Cells and Control of Brain Disease After Focal Radiation Therapy of Breast Cancer Brain Metastases
por: Guedes de Castro, Douglas, et al.
Publicado: (2021)

Whole-Brain Radiotherapy vs. Localized Radiotherapy after Resection of Brain Metastases in the Era of Targeted Therapy: A Retrospective Study
por: Koo, Jaho, et al.
Publicado: (2021)

Radiotherapy for Brain Metastases Near the End of Life: Characterizing Patients and Tumor Features
por: Silva, Saulo Brito, et al.
Publicado: (2023)

A Case of Brain Metastases from Breast Cancer Treated with Whole-Brain Radiotherapy and Eribulin Mesylate
por: Nieder, Carsten, et al.
Publicado: (2012)

Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible
por: Fogarty, Gerald B, et al.
Publicado: (2014)

Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy
por: Frisk, Gabriella, et al.
Publicado: (2017)

Effectiveness of temozolomide combined with whole brain radiotherapy for non‐small cell lung cancer brain metastases
por: Zhu, Ying, et al.
Publicado: (2018)

From Whole-Brain Radiotherapy to Immunotherapy: A Multidisciplinary Approach for Patients with Brain Metastases from NSCLC
por: Protopapa, Maria, et al.
Publicado: (2019)

Survival time and prognostic factors after whole-brain radiotherapy of brain metastases from of breast cancer
por: Okada, Yukinori, et al.
Publicado: (2020)

Repeated stereotactic radiosurgery for the treatment of relapsed brain metastases: is it time to give up whole-brain radiotherapy?
por: Nicosia, Luca, et al.
Publicado: (2020)

Whole brain radiotherapy for brain metastasis
por: McTyre, Emory, et al.
Publicado: (2013)

Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan
por: Lo, Serigne N., et al.
Publicado: (2019)

Comparison of whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases to boost irradiation in the treatment of brain metastases from SCLC: study protocol for a randomized controlled trial
por: Zhang, Xiaofang, et al.
Publicado: (2022)

Prophylactic corticosteroid to prevent pain flare in bone metastases treated by radiotherapy
por: Viani, Gustavo Arruda, et al.
Publicado: (2021)

A Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4–10 brain metastases
por: Hartgerink, Dianne, et al.
Publicado: (2021)

Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection—Outcome, Prognostic Factors, and Recurrence Patterns
por: El Shafie, Rami A., et al.
Publicado: (2020)

Survival and quality of life after whole brain radiotherapy with 3D conformal boost in the treatment of brain metastases
por: Suteu, Patricia, et al.
Publicado: (2019)

Distribution of brain metastases: low-risk metastasis areas may be avoided when treating with whole-brain radiotherapy
por: Lin, Binwei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vjnhustpm0i3hsu18rj2a9q02o